These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 20873125)
1. [Statins in the treatment of polycystic ovary syndrome]. Banaszewska B; Spaczyński R; Pawelczyk L Ginekol Pol; 2010 Aug; 81(8):618-21. PubMed ID: 20873125 [TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome? Kodaman PH; Duleba AJ Drugs; 2008; 68(13):1771-85. PubMed ID: 18729532 [TBL] [Abstract][Full Text] [Related]
3. Statins in the treatment of polycystic ovary syndrome. Kodaman PH; Duleba AJ Semin Reprod Med; 2008 Jan; 26(1):127-38. PubMed ID: 18181091 [TBL] [Abstract][Full Text] [Related]
4. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome. Diamanti-Kandarakis E; Kandaraki E; Christakou C; Panidis D Obes Rev; 2009 Jul; 10(4):431-41. PubMed ID: 19413702 [TBL] [Abstract][Full Text] [Related]
5. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations. Koo YA; Shin SY; Yoon BK; Choi D Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414 [TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials. Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801 [TBL] [Abstract][Full Text] [Related]
7. The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Chen J; Huang C; Zhang T; Gong W; Deng X; Liu H; Liu J; Guo Y Reprod Biol Endocrinol; 2021 Dec; 19(1):189. PubMed ID: 34930305 [TBL] [Abstract][Full Text] [Related]
8. The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date. Kolnikaj TS; Herman R; Janež A; Jensterle M Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399531 [TBL] [Abstract][Full Text] [Related]
9. Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome. Banaszewska B; Pawelczyk L; Spaczynski R Reprod Biol; 2019 Dec; 19(4):309-315. PubMed ID: 31606349 [TBL] [Abstract][Full Text] [Related]
10. Statin ameliorates endothelial dysfunction and insulin resistance in Tibet women with polycystic ovary syndrome. Yang B; Sun ZJ; Chen B; Zhang J; Zhao H; Li CW; Cao YK; Cao F Eur Rev Med Pharmacol Sci; 2016; 20(6):1185-91. PubMed ID: 27049276 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study. Kaya C; Pabuccu R; Cengiz SD; Dünder I Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):161-6. PubMed ID: 20146169 [TBL] [Abstract][Full Text] [Related]
13. Statin is a reasonable treatment option for patients with Polycystic Ovary Syndrome: a meta-analysis of randomized controlled trials. Gao L; Zhao FL; Li SC Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):367-75. PubMed ID: 22639397 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of prolonged use of statins on the clinical and biochemical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome. Seyam E; Al Gelany S; Abd Al Ghaney A; Mohamed MAA; Youseff AM; Ibrahim EM; Khalifa EM; Hefzy E Gynecol Endocrinol; 2018 Jul; 34(7):589-596. PubMed ID: 29258367 [TBL] [Abstract][Full Text] [Related]
15. Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights. Westerveld HE; Hoogendoorn M; de Jong AW; Goverde AJ; Fauser BC; Dallinga-Thie GM Pharmacol Ther; 2008 Sep; 119(3):223-41. PubMed ID: 18602948 [TBL] [Abstract][Full Text] [Related]
16. Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome. Stabile G; Borrielli I; Artenisio AC; Bruno LM; Benvenga S; Giunta L; La Marca A; Volpe A; Pizzo A J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):177-82. PubMed ID: 24814528 [TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association. Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824 [TBL] [Abstract][Full Text] [Related]
18. The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study. Sathyapalan T; Kilpatrick ES; Coady AM; Atkin SL J Clin Endocrinol Metab; 2009 Jan; 94(1):103-8. PubMed ID: 18940877 [TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia and oxidative stress in PCOS. Macut D; Bjekić-Macut J; Savić-Radojević A Front Horm Res; 2013; 40():51-63. PubMed ID: 24002405 [TBL] [Abstract][Full Text] [Related]
20. Dyslipidemia involvement in the development of polycystic ovary syndrome. Liu Q; Xie YJ; Qu LH; Zhang MX; Mo ZC Taiwan J Obstet Gynecol; 2019 Jul; 58(4):447-453. PubMed ID: 31307731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]